Managers
Harvest Partners, a New York-based private equity firm, has completed the acquisition of FCX Performance, in partnership with existing management, from Sterling Investment Partners.
Sterling will maintain an ownership stake in the company. Terms of the transaction were not disclosed.
Based in Columbus, Ohio, FCX is an industrial, specialty process flow control distribution company, providing technical, mission-critical products and value-added services to more than 15,000 end users, original equipment manufacturers and engineering and construction firms across the process, energy and high purity industries. The company’s target end markets include chemicals; upstream, midstream and downstream oil and gas; power; steel; pulp
Grey Mountain Partners has acquired the assets of North American Specialty Glass (NASG) out of Chapter 7 Bankruptcy.
Headquartered in Pennsylvania, NASG is one of the largest safety and security glass producers in the US, serving customers worldwide with high-performance transparency systems for transportation, architectural, military and other specialty end-use applications.
Additionally, NASG is an industry leader in the development of glass and polycarbonate laminate technology.
Tom Ryan, chief executive of Consolidated Glass Holdings, an affiliate of Grey Mountain Partners, says: “With a commitment to customer service and quality products, NASG has a reputation for providing consistently superior laminated glazing
European Capital and its affiliates have received proceeds of EUR27.9m by exiting their existing investments in Unipex Group.
European Capital has also completed a EUR20m investment in the multi-currency (including USD and EUR) unitranche bonds supporting the Unipex Group’s acquisition by IK2007 Fund, advised by IK Investment Partners.
Both transactions occurred in September 2012.
Unipex Group is a manufacturer and distributor of natural active ingredients and specialty chemicals for the cosmetic, pharmaceutical, nutrition and industrial sectors. Unipex Group has completed four build-up acquisitions extending both its geographic reach and product offering.
In May 2008, European Capital invested USD22m in a
WL Ross has completed the purchase of 4.4 million common shares of Navigator owned by Lehman Brothers Inc (LBI) for approximately USD110m.
The transaction was approved by Bankruptcy Judge James M Peck of the Bankruptcy Court in the Southern District of New York overseeing LBI’s liquidation in connection with LBI Trustee James W. Giddens’ role in maximising value for the shares for the benefit of customers and general creditors.
The purchase brings WL Ross’ total stake in Navigator to over 50 per cent. As part of the transaction, WL Ross agreed with Navigator to various limitations, including that a majority
Private equity firm Ampersand Capital Partners has sold medical device design company MedVenture Technology to Helix Medical, a manufacturer for the medical device and healthcare industries.
Established in 1998, MedVenture is headquartered in the Louisville, Kentucky metropolitan area and employs over 260 associates. MedVenture develops and manufactures minimally invasive surgical devices and catheter-based devices for medical device companies, including Fortune 500 and medical device start-ups. The company develops integrated solutions for the endovascular, interventional cardiology, cardiovascular surgery, neurovascular, urology, oncology, and gynecology markets, among others.
The acquisition will enhance Helix Medical’s ability to offer its customers a full spectrum of
Maranon Capital has made an investment in Performance Health and Wellness Holdings to support the acquisition of the business by Gridiron Capital and Performance Health’s management team.
Maranon arranged and led a syndicate that provided mezzanine debt and an equity co-investment.
Headquartered in Akron, Ohio, Performance Health is a designer, manufacturer and marketer of branded rehabilitation and wellness products. The company’s products include a line of topical analgesics and a broad range of rehabilitation and wellness products including progressive resistance bands and tubing, exercise balls, hand exercisers, stability trainers and a number of other specialty products. In addition, the company
Preqin’s initial public offering pipeline data reveals that there are currently 42 private equity and venture capital-backed companies globally set to list in the coming weeks, seeking to raise USD8.4bn in public offerings.
Twenty-four of these companies are buyout-backed, and a further 18 VC-backed companies have currently filed for an IPO.
In addition, as of 15 October, 19 PE-and VC-backed companies have completed their IPOs or follow-on share sales during the month, raising USD4bn in their offerings. This is in marked contrast to the whole of Q3 2012, when USD6.5bn was raised in public offerings during the whole quarter, indicating
Accel-KKR, a technology-focused private equity investment firm, has made a majority equity investment in Accellos, a supply chain execution software company focused on the SMB segment.
Accel-KKR is backing Accellos as it drives growth and rapid adoption of its unified suite of supply chain execution solutions.
Accellos was founded with a vision that small and mid-sized business, and logistics service providers were in need of a single-source supply chain software partner. This vision has manifested itself in the acquisition and integration of six supply chain software companies and the development of a unifying product technology – the AccellosOne platform. Over
Funds advised by IK Investment Partners are to acquire a majority of the shares in Vemedia Pharma, a supplier and distributor of over the counter medicines in the specialist areas of sleeping and calming products and vitamins.
The acquisition agreement was entered into with the three largest shareholders of Vemedia following a competitive auction process run by ING and Michel Dyens & Co. Bank Degroof was acting as adviser to IK.
The selling shareholders are Damier, controlled by Vemedia’s chief executive Yvan Vindevogel, Indufin Capital Partners (an investment company jointly owned by listed investment company Luxempart and investment company De
Funds advised by European private equity fund PAI Partners are to purchase a 78.39 per cent stake in Marcolin, an Italian eyewear manufacturer, at a price of EUR4.25 per share from family and private owners in a proprietary primary LBO transaction in one of its core investment sectors.
On completion, PAI Partners will promote a mandatory public tender offer for the remaining equity, which is publicly traded, at EUR4.25 per share, with the aim of de-listing the company. The transaction is expected to close in late November.
Marcolin is one of the largest and fastest growing eyewear manufacturers in Italy
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
